APO Research
Talk to an analyst

APO RESEARCH · REPORT

HPV Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global HPV Vaccines Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchHPV Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal HPV Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal HPV Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HPV Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal HPV Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global HPV Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the HPV Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the HPV Vaccines market include Johnson & Johnson, Merck, Pfizer, GlaxoSmithKline, Serum Institute, Sanofi Pasteur, MedImmune, Emergent BioSolutions and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global HPV Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HPV Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HPV Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the HPV Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

HPV Vaccines Segment by Company

Johnson & Johnson

Merck

Pfizer

GlaxoSmithKline

Serum Institute

Sanofi Pasteur

MedImmune

Emergent BioSolutions

CSL

Astellas Pharma

HPV Vaccines Segment by Type

Adolescents

Adults

HPV Vaccines Segment by Application

Male

Female

HPV Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global HPV Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions HPV Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify HPV Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze HPV Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HPV Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the HPV Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HPV Vaccines industry.

Chapter 3: Detailed analysis of HPV Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of HPV Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of HPV Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. HPV Vaccines Industry Trends Table 2. HPV Vaccines Industry Drivers Table 3. HPV Vaccines Industry Opportunities and Challenges Table 4. HPV Vaccines Industry Restraints Table 5. Global HPV Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global HPV Vaccines Revenue Share by Company (2021-2026) Table 7. Global HPV Vaccines Sales Volume by Company (k units) & (2021-2026) Table 8. Global HPV Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global HPV Vaccines Average Price (US$/unit) of Company (2021-2026) Table 10. Global HPV Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global HPV Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global HPV Vaccines Company, Product Type & Application Table 13. Global HPV Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global HPV Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Adolescents Table 18. Significant Companies of Adults Table 19. Global HPV Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global HPV Vaccines Sales Volume by Type (2021-2026) & (k units) Table 21. Global HPV Vaccines Sales Volume by Type (2027-2032) & (k units) Table 22. Global HPV Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global HPV Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global HPV Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global HPV Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global HPV Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global HPV Vaccines Sales Value Share by Type (2021-2026) Table 28. Global HPV Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Male Table 30. Significant Companies of Female Table 31. Global HPV Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global HPV Vaccines Sales Volume by Application (2021-2026) & (k units) Table 33. Global HPV Vaccines Sales Volume by Application (2027-2032) & (k units) Table 34. Global HPV Vaccines Sales Volume Share by Application (2021-2026) Table 35. Global HPV Vaccines Sales Volume Share by Application (2027-2032) Table 36. Global HPV Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global HPV Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global HPV Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global HPV Vaccines Sales Value Share by Application (2021-2026) Table 40. Global HPV Vaccines Sales Value Share by Application (2027-2032) Table 41. Global HPV Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global HPV Vaccines Sales by Region (2021-2026) & (k units) Table 43. Global HPV Vaccines Sales Market Share by Region (2021-2026) Table 44. Global HPV Vaccines Sales by Region (2027-2032) & (k units) Table 45. Global HPV Vaccines Sales Market Share by Region (2027-2032) Table 46. Global HPV Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global HPV Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global HPV Vaccines Sales Value Share by Region (2021-2026) Table 49. Global HPV Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global HPV Vaccines Sales Value Share by Region (2027-2032) Table 51. Global HPV Vaccines Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global HPV Vaccines Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global HPV Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global HPV Vaccines Sales by Country (2021-2026) & (k units) Table 56. Global HPV Vaccines Sales Market Share by Country (2021-2026) Table 57. Global HPV Vaccines Sales by Country (2027-2032) & (k units) Table 58. Global HPV Vaccines Sales Market Share by Country (2027-2032) Table 59. Global HPV Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global HPV Vaccines Sales Value Market Share by Country (2021-2026) Table 61. Global HPV Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global HPV Vaccines Sales Value Market Share by Country (2027-2032) Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson HPV Vaccines Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck HPV Vaccines Product Portfolio Table 72. Merck Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Pfizer HPV Vaccines Product Portfolio Table 77. Pfizer Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline HPV Vaccines Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Serum Institute Company Information Table 84. Serum Institute Business Overview Table 85. Serum Institute HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Serum Institute HPV Vaccines Product Portfolio Table 87. Serum Institute Recent Development Table 88. Sanofi Pasteur Company Information Table 89. Sanofi Pasteur Business Overview Table 90. Sanofi Pasteur HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Sanofi Pasteur HPV Vaccines Product Portfolio Table 92. Sanofi Pasteur Recent Development Table 93. MedImmune Company Information Table 94. MedImmune Business Overview Table 95. MedImmune HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. MedImmune HPV Vaccines Product Portfolio Table 97. MedImmune Recent Development Table 98. Emergent BioSolutions Company Information Table 99. Emergent BioSolutions Business Overview Table 100. Emergent BioSolutions HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Emergent BioSolutions HPV Vaccines Product Portfolio Table 102. Emergent BioSolutions Recent Development Table 103. CSL Company Information Table 104. CSL Business Overview Table 105. CSL HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. CSL HPV Vaccines Product Portfolio Table 107. CSL Recent Development Table 108. Astellas Pharma Company Information Table 109. Astellas Pharma Business Overview Table 110. Astellas Pharma HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Astellas Pharma HPV Vaccines Product Portfolio Table 112. Astellas Pharma Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. HPV Vaccines Distributors List Table 116. HPV Vaccines Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. HPV Vaccines Product Image Figure 2. Global HPV Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HPV Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global HPV Vaccines Sales (2021-2032) & (k units) Figure 5. Global HPV Vaccines Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global HPV Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Adolescents Image Figure 10. Adults Image Figure 11. Global HPV Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global HPV Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global HPV Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global HPV Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global HPV Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global HPV Vaccines Sales Value Share by Type (2021-2032) Figure 17. Male Image Figure 18. Female Image Figure 19. Global HPV Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global HPV Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global HPV Vaccines Sales Volume Share by Application (2021-2032) Figure 22. Global HPV Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global HPV Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global HPV Vaccines Sales Value Share by Application (2021-2032) Figure 25. Global HPV Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global HPV Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global HPV Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global HPV Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America HPV Vaccines Sales Value (2021-2032) & (US$ Million) Figure 30. North America HPV Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe HPV Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. Europe HPV Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific HPV Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific HPV Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America HPV Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. South America HPV Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa HPV Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa HPV Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt HPV Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt HPV Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt HPV Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. HPV Vaccines Value Chain Figure 124. Manufacturing Cost Structure Figure 125. HPV Vaccines Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Adolescents
  • Adults
Applications
  • Male
  • Female
Companies covered
  • Johnson & Johnson
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Serum Institute
  • Sanofi Pasteur
  • MedImmune
  • Emergent BioSolutions
  • CSL
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HPV Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global HPV Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global HPV Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 HPV Vaccines Market Dynamics
  1. 2.1 HPV Vaccines Industry Trends
  2. 2.2 HPV Vaccines Industry Drivers
  3. 2.3 HPV Vaccines Industry Opportunities and Challenges
  4. 2.4 HPV Vaccines Industry Restraints
3 HPV Vaccines Market by Company
  1. 3.1 Global HPV Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global HPV Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global HPV Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global HPV Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global HPV Vaccines Company Ranking (2024-2026)
  6. 3.6 Global HPV Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global HPV Vaccines Company Product Type and Application
  8. 3.8 Global HPV Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global HPV Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 HPV Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 HPV Vaccines Market by Type
  1. 4.1 HPV Vaccines Type Introduction
  2. 4.1.1 Adolescents
  3. 4.1.2 Adults
  4. 4.2 Global HPV Vaccines Sales Volume by Type
  5. 4.2.1 Global HPV Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global HPV Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global HPV Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global HPV Vaccines Sales Value by Type
  9. 4.3.1 Global HPV Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global HPV Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global HPV Vaccines Sales Value Share by Type (2021-2032)
5 HPV Vaccines Market by Application
  1. 5.1 HPV Vaccines Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global HPV Vaccines Sales Volume by Application
  5. 5.2.1 Global HPV Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global HPV Vaccines Sales Volume by Application (2021-2032)
  7. 5.2.3 Global HPV Vaccines Sales Volume Share by Application (2021-2032)
  8. 5.3 Global HPV Vaccines Sales Value by Application
  9. 5.3.1 Global HPV Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global HPV Vaccines Sales Value by Application (2021-2032)
  11. 5.3.3 Global HPV Vaccines Sales Value Share by Application (2021-2032)
6 HPV Vaccines Regional Sales and Value Analysis
  1. 6.1 Global HPV Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global HPV Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global HPV Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global HPV Vaccines Sales by Region (2027-2032)
  5. 6.3 Global HPV Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global HPV Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global HPV Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global HPV Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global HPV Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America HPV Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America HPV Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe HPV Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe HPV Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific HPV Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific HPV Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America HPV Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America HPV Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa HPV Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa HPV Vaccines Sales Value Share by Country, 2025 VS 2032
7 HPV Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global HPV Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global HPV Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global HPV Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global HPV Vaccines Sales by Country (2027-2032)
  6. 7.4 Global HPV Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global HPV Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global HPV Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA HPV Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada HPV Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico HPV Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany HPV Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France HPV Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. HPV Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy HPV Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain HPV Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia HPV Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands HPV Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries HPV Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China HPV Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan HPV Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea HPV Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India HPV Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia HPV Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia HPV Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil HPV Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina HPV Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile HPV Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia HPV Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru HPV Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia HPV Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel HPV Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE HPV Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey HPV Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran HPV Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran HPV Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt HPV Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt HPV Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt HPV Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson HPV Vaccines Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck HPV Vaccines Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer HPV Vaccines Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline HPV Vaccines Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Serum Institute
  26. 8.5.1 Serum Institute Company Information
  27. 8.5.2 Serum Institute Business Overview
  28. 8.5.3 Serum Institute HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute HPV Vaccines Product Portfolio
  30. 8.5.5 Serum Institute Recent Developments
  31. 8.6 Sanofi Pasteur
  32. 8.6.1 Sanofi Pasteur Company Information
  33. 8.6.2 Sanofi Pasteur Business Overview
  34. 8.6.3 Sanofi Pasteur HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur HPV Vaccines Product Portfolio
  36. 8.6.5 Sanofi Pasteur Recent Developments
  37. 8.7 MedImmune
  38. 8.7.1 MedImmune Company Information
  39. 8.7.2 MedImmune Business Overview
  40. 8.7.3 MedImmune HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MedImmune HPV Vaccines Product Portfolio
  42. 8.7.5 MedImmune Recent Developments
  43. 8.8 Emergent BioSolutions
  44. 8.8.1 Emergent BioSolutions Company Information
  45. 8.8.2 Emergent BioSolutions Business Overview
  46. 8.8.3 Emergent BioSolutions HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Emergent BioSolutions HPV Vaccines Product Portfolio
  48. 8.8.5 Emergent BioSolutions Recent Developments
  49. 8.9 CSL
  50. 8.9.1 CSL Company Information
  51. 8.9.2 CSL Business Overview
  52. 8.9.3 CSL HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 CSL HPV Vaccines Product Portfolio
  54. 8.9.5 CSL Recent Developments
  55. 8.10 Astellas Pharma
  56. 8.10.1 Astellas Pharma Company Information
  57. 8.10.2 Astellas Pharma Business Overview
  58. 8.10.3 Astellas Pharma HPV Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Astellas Pharma HPV Vaccines Product Portfolio
  60. 8.10.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 HPV Vaccines Value Chain Analysis
  2. 9.1.1 HPV Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 HPV Vaccines Sales Mode & Process
  6. 9.2 HPV Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 HPV Vaccines Distributors
  9. 9.2.3 HPV Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst